Metabolic Therapies: Perseo pharma is a preclinical stage biotech start-up developing a pipeline of digestive therapies based on a proprietary enzyme therapeutics nanotechnology platform.
Products, services, technology
Our pipeline is focused on digestive therapies for Exocrine Pancreatic Insufficiency, Acquired Lactase Deficiency, Congenital Sucrase Deficiency, and Phenylketonuria. Additionally, our enzyme therapeutics platform can be applied to Systemic Enzyme Replacement Therapies and Oncology.
Two of our pipeline products are being developed jointly with an industry player. Perseo pharma is open to such joint developments and to granting access to its proprietary enzyme therapeutics platform.